• Chromogranin A
  • Plasma Cell Assessment by Flow Cytometry, Blood
  • Imipramine, Serum
  • von Willebrand Factor Multimer Analysis, Plasma
  • Islet Cell (IA-2) Autoantibodies
  • ATM/C11orf65 Gene Variation
  • Methemoglobin
  • MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • Alkaline Phosphatase (ALP), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Oncology Pharmacogenetics (PGx) Gene Variation Panel
Medical Test

ICD10
Access to Oncology Pharmacogenetics (PGx) Gene Variation Panel is restricted.